Q1 FY27 snapshot
Announcement Date12-Aug-26
Revenue (Top Line)₹ 841 Cr
Net Profit (Bottom Line)₹ 159 Cr
Earnings Per Share (EPS)₹3.47
Expenses₹ 628 Cr
Net profit margin (calculated)18.9%
Marksans Pharma Ltd (MARKSANS) Quarterly Results: Q1 FY27
Quick answer: Marksans Pharma Ltd (NSE: MARKSANS) reported Q1 FY27 revenue of ₹ 841 Cr and net profit of ₹ 159 Cr, with earnings per share (EPS) of ₹3.47, announced on 12-Aug-26.
That works out to a net profit margin of about 18.9% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Marksans Pharma Ltd's Q1 FY27 results
Revenue of ₹ 841 Cr is what Marksans Pharma Ltd earned before costs. Net profit of ₹ 159 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 18.9%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Marksans Pharma Ltd results FAQs
What were Marksans Pharma Ltd's Q1 FY27 results?
Marksans Pharma Ltd (NSE: MARKSANS) reported Q1 FY27 revenue of ₹ 841 Cr and net profit of ₹ 159 Cr, with earnings per share (EPS) of ₹3.47, announced on 12-Aug-26.
What is Marksans Pharma Ltd's EPS for Q1 FY27?
Marksans Pharma Ltd's earnings per share for Q1 FY27 was ₹3.47. EPS is net profit divided by the number of outstanding shares.
When did Marksans Pharma Ltd announce its Q1 FY27 results?
Marksans Pharma Ltd announced its Q1 FY27 results on 12-Aug-26.
What is Marksans Pharma Ltd's net profit margin?
On the reported figures, Marksans Pharma Ltd's Q1 FY27 net profit margin is about 18.9% (net profit ÷ revenue).